- Jennifer Woo
Robust research in the field of pediatric rheumatology is important to better understand disease manifestations, to identify best practices and treatments, and most importantly, to address the burden of these diseases on the lives of patients and their families. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) is a non-profit organization dedicated to conducting collaborative research to prevent, treat and cure pediatric rheumatic diseases. The organization is comprised of physicians, researchers, nurses and research coordinators, and patient and family members, representing over 65 pediatric rheumatology centers in North America and abroad. In order to ensure that CARRA is uniformly collecting the most up-to-date measures to capture the different rheumatic diseases, stakeholders must be aware of any novel treatments and disease measures and receive refreshers on current practices. Without uniformity in the use and implementation of research measures and clinical practice, comparisons among sites would be impossible and likely contribute to extraneous conclusions. This continuing education series is designed to create a uniform platform that introduces aspects of the changing landscape of pediatric rheumatology practice, incorporating clinical, research, and patient/family perspectives in order to conduct efficient and effective research that will better the lives of children with rheumatic disease.
APPs, MD, DO, Pediatric Rheumatologists, RN, APRN, Physician Assistants, and Students.
|Joni Dean, RN, PNP, RSS Chair||Mary Ellen Riordan, BSN, CCRC|
|Jen Woo, MPH||Dominic Co, MD PhD|
|Chelsey Smith, CCRC|
|In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the Childhood Arthritis and Rheumatology Research Alliance . The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hour.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1.0 hours.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
As a result of participation in this educational series, learners will be able to:
- Apply the common criteria for diagnosis and measures used to capture the disease activity or severity of rheumatic diseases.
- Approach pediatric patients with rheumatic diseases and families with the measures to collect accurate data about the disease and effects of treatment.
- Administer (or assist in administering) the presented disease measures, explain what data are being collected and their importance, and collect and report necessary data to ensure that the measures are complete.
- Improve interprofessional communication, and collaborative care and research in the area of pediatric rheumatic diseases.